391 related articles for article (PubMed ID: 16894464)
1. Formation of tissue factor-factor VIIa-factor Xa complex prevents apoptosis in human breast cancer cells.
Jiang X; Guo YL; Bromberg ME
Thromb Haemost; 2006 Aug; 96(2):196-201. PubMed ID: 16894464
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin induces apoptosis in human breast cancer cells in a NFkappaB-dependent manner and abolishes the anti-apoptotic signaling of TF/FVIIa and TF/FVIIa/FXa.
Aberg M; Wickström M; Siegbahn A
Thromb Res; 2008; 122(2):191-202. PubMed ID: 18031796
[TBL] [Abstract][Full Text] [Related]
3. Coagulation factors VIIa and Xa inhibit apoptosis and anoikis.
Versteeg HH; Spek CA; Richel DJ; Peppelenbosch MP
Oncogene; 2004 Jan; 23(2):410-7. PubMed ID: 14724569
[TBL] [Abstract][Full Text] [Related]
4. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
Norledge BV; Petrovan RJ; Ruf W; Olson AJ
Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
[TBL] [Abstract][Full Text] [Related]
5. Formation of tissue factor-factor VIIa-factor Xa complex induces activation of the mTOR pathway which regulates migration of human breast cancer cells.
Jiang X; Zhu S; Panetti TS; Bromberg ME
Thromb Haemost; 2008 Jul; 100(1):127-33. PubMed ID: 18612547
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer.
Taniguchi T; Kakkar AK; Tuddenham EG; Williamson RC; Lemoine NR
Cancer Res; 1998 Oct; 58(19):4461-7. PubMed ID: 9766679
[TBL] [Abstract][Full Text] [Related]
7. Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex.
Sato Y; Asada Y; Marutsuka K; Hatakeyama K; Kamikubo Y; Sumiyoshi A
Thromb Haemost; 1997 Sep; 78(3):1138-41. PubMed ID: 9308767
[TBL] [Abstract][Full Text] [Related]
8. Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells.
Jiang X; Bailly MA; Panetti TS; Cappello M; Konigsberg WH; Bromberg ME
J Thromb Haemost; 2004 Jan; 2(1):93-101. PubMed ID: 14717972
[TBL] [Abstract][Full Text] [Related]
9. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation.
Cirillo P; Calì G; Golino P; Calabrò P; Forte L; De Rosa S; Pacileo M; Ragni M; Scopacasa F; Nitsch L; Chiariello M
Circulation; 2004 Jun; 109(23):2911-6. PubMed ID: 15173027
[TBL] [Abstract][Full Text] [Related]
10. Tissue Factor/ FVIIa prevents the extrinsic pathway of apoptosis by regulation of the tumor suppressor Death-Associated Protein Kinase 1 (DAPK1).
Aberg M; Johnell M; Wickström M; Siegbahn A
Thromb Res; 2011 Feb; 127(2):141-8. PubMed ID: 21168190
[TBL] [Abstract][Full Text] [Related]
11. The influence of exogenous tissue factor on the regulators of proliferation and apoptosis in endothelial cells.
Pradier A; Ettelaie C
J Vasc Res; 2008; 45(1):19-32. PubMed ID: 17898544
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa.
Ollivier V; Chabbat J; Herbert JM; Hakim J; de Prost D
Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1374-81. PubMed ID: 10807756
[TBL] [Abstract][Full Text] [Related]
13. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
14. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tissue factor-factor VIIa proteolytic activity blunts hepatic metastasis in colorectal cancer.
Zerbib P; Grimonprez A; Corseaux D; Mouquet F; Nunes B; Petersen LC; Susen S; Ung A; Hebbar M; Pruvot FR; Chambon JP; Jude B
J Surg Res; 2009 May; 153(2):239-45. PubMed ID: 19062044
[TBL] [Abstract][Full Text] [Related]
16. Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor.
Poulsen LK; Jacobsen N; Sørensen BB; Bergenhem NC; Kelly JD; Foster DC; Thastrup O; Ezban M; Petersen LC
J Biol Chem; 1998 Mar; 273(11):6228-32. PubMed ID: 9497347
[TBL] [Abstract][Full Text] [Related]
17. Protein disulfide isomerase has no stimulatory chaperone effect on factor X activation by factor VIIa-soluble tissue factor.
Persson E
Thromb Res; 2008; 123(1):171-6. PubMed ID: 18550154
[TBL] [Abstract][Full Text] [Related]
18. Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Rac1 and the mitogen-activated protein kinase p38.
Ott I; Weigand B; Michl R; Seitz I; Sabbari-Erfani N; Neumann FJ; Schömig A
Circulation; 2005 Jan; 111(3):349-55. PubMed ID: 15642762
[TBL] [Abstract][Full Text] [Related]
19. Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions.
Hathcock JJ; Rusinova E; Gentry RD; Andree H; Nemerson Y
Biochemistry; 2005 Jun; 44(22):8187-97. PubMed ID: 15924438
[TBL] [Abstract][Full Text] [Related]
20. Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study.
Petersen LC; Nørby PL; Branner S; Sørensen BB; Elm T; Stennicke HR; Persson E; Bjørn SE
Thromb Res; 2005; 116(1):75-85. PubMed ID: 15850611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
